Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus ##STR00001##

 
Web www.patentalert.com

< Crystal and process for producing the same

< Supplemented and unsupplemented tissue sealants, methods of their production and use

> PKB-3564 substance with neovascularization inhibitory activity

> Method for the treatment of incontinence
~ 00291